Selective immunoadsorption in neurologic complications of systemic lupus erythematosus;Selektive immunadsorption bei neurologischen komplikationen eines systemischen lupus erythematodes

Nervenarzt

Volumn 78, Issue 4, 2007, Pages 441-444

  Harscher, S ^a   Rummler, S ^a   Oelzner, P ^a   Mentzel, H J ^a   Brodhun, M ^a   Witte, O W ^a   Terborg, C ^a   Isenmann, S ^a,b,c  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b HELIOS KLINIKUM WUPPERTAL   (Germany)

^c St Joseph Hospital   (Germany)

Author keywords

Selective immunoadsorption; Systemic lupus erythematosus; Vasculitis

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; PREDNISOLONE; RO ANTIBODY;

AGED; APHASIA; ARTICLE; AUTOIMMUNE DISEASE; BLOOD FLOW VELOCITY; BRAIN BLOOD FLOW; BRAIN INFARCTION; CASE REPORT; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; COMPLEX PARTIAL SEIZURE; DISORIENTATION; DOPPLER ECHOGRAPHY; EPILEPSY; FEMALE; HALLUCINATION; HOSPITAL ADMISSION; HUMAN; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; MENTAL DEFICIENCY; MENTAL DISEASE; NERVE BIOPSY; NEUROLOGICAL COMPLICATION; NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PARESIS; PARESTHESIA; PERIPHERAL NERVOUS SYSTEM; RAYNAUD PHENOMENON; SENSORY DYSFUNCTION; SEROLOGY; SJOEGREN SYNDROME; SURAL NERVE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC VASCULITIS;

AGED; ANTIBODIES, ANTINUCLEAR; BRAIN; FEMALE; HUMANS; IMMUNOSORBENT TECHNIQUES; IMMUNOSUPPRESSIVE AGENTS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; NERVOUS SYSTEM DISEASES; TREATMENT OUTCOME;

EID: 34247175867     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-006-2252-2     Document Type: Article

References (11)

1. Berlit P (2004) Zerebrale Vaskulitis. Nervenarzt 75(8): 817-828
2. Berlit P, Steinbrecher A (2002) Zerebrale Vaskulitis. Fortschr Neurol Psychiatr 70(12): 663-677
3. Ferro JM (1998) Vasculitis of the central nervous system. J Neurol 245(12): 766-776
4. Bluestein HG (1987) Neuropsychiatric manifestations of systemic lupus erythematosus. N Engl J Med 317(5): 309-311
5. Neuwelt CM (2003) The role of plasmapheresis in the treatment of severe central nervous system neuropsychiatric systemic lupus erythematosus. Ther Apher Dial 7(2): 173-182
6. Haupt WF et al. (2000) Immunoadsorption in Guillain-Barre syndrome and myasthenia gravis. Ther Apher 4(3): 195-197
7. Grob D et al. (1995) Treatment of myasthenia gravis by immunoadsorption of plasma. Neurology 45(2): 338-344
8. Schmaldienst S et al. (2002) Treatment of systemic lupus erythematosus by immunoadsorption in a patient suffering from tuberculosis. Am J Kidney Dis 39(2): 415-418
9. Graninger W (1996) [Aggressive therapy of highly active systemic lupus erythematosus]. Acta Med Austriaca 23(4): 129-133
10. Fukui W et al. (1998) [A case of severe neuropsychiatric lupus erythematosus treated by plasmapheresis: diagnostic values of serum antiribosomal P protein antibodies and interleukin-6 in cerebrospinal fluid]. Nihon Rinsho Meneki Gakkai Kaishi 21(4): 172-179
11. Schiel R, Bambauer R (1999) Therapeutic plasma exchange and cyclosporine in the treatment of systemic lupus erythematosus. Ther Apher 3(3): 234-239